1Horwitz DA,Jacob CO. The Cytokine net work in the pathogenesis of systemic lupus erythematasus and possible therapeutic implication, Spring Semin Immunopathol, 1994,16:181.
2Mempel K, Pietseh T, Menzel T, et al. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood, 1991,77:1919-1922.
3Sugihara A, Adachi Y, Inaba M, et al. Age-dependant abnormalities of hematopoietic stem cell in (NZWX BXSB)F1 mice. Stem Cells, 1999,17 : 357-365.
4Courtney PA, Crockard AD, Williamson K, et al. Increased apoptotic peripheral blood neutrophils in systemic lupus erythymatosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis,1999,58:309-314.
3Sahid El Radhi A, Hogg C L, Bungre J K, et al. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma[ J ]. Arch Dis Child ,2000,83 ( 2 ) : 158-162.
4Deresinski S. Granulocyte-macrophage colony-stimulating factor: potential therapeutic, immunological and antiretroviral effects in HIV infection[J]. AIDS, 1999,13 ( 6 ) :633-643.
5Tanaka N, Watanabe J, Kitamura T, et al. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor [ J ]. FE BS Lett, 1999,442 ( 2-3 ) : 246-250.
6Kavuru M S, Bonfield T L,Thomassen M J. Plasmapheresis, GM-CSF, and alveolar proteinosis[ J ]. Am J Respir Crit Care Med ,2003,167 ( 7 ) : 1036-1037.
7Seeto C, Namkung Matthai H, Jayrams S, et al. Differential potency of beclomechosone ester in-vitro on human T-lymphocyte cytokine production and osteoblast activity [ J]. J Pharm Pharm Pharmacol,2000,52 (4) :417-423.
